本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NEWAMSTERDAM PHARMA CO NV

20.19
-1.0600-4.99%
盤後:20.200.0100+0.05%19:30 EDT
成交量:98.97萬
成交額:2,018.96萬
市值:24.13億
市盈率:-9.42
高:21.34
開:21.20
低:20.04
收:21.25
52周最高:42.21
52周最低:20.04
股本:1.20億
流通股本:9,075.68萬
量比:0.77
換手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
淨資產收益率:-36.81%
總資產收益率:-20.11%
市淨率:3.82
市盈率(LYR):-11.73

資料載入中...

2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/18

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/05

重要事件披露

Form 8-K - Current report